CMV
Together we can help transform the lives of children born with cytomegalovirus (CMV)
Can you help raise the first £10,000 towards research that could improve outcomes for babies born with CMV?
Cytomegalovirus (CMV), is a common virus that for most people is harmless, but for babies with congenital CMV, where they’ve contracted the virus in the womb, it can pose a serious risk to their health.
Two to three babies born every day in the UK will have permanent disabilities as a result of CMV. Yet there is no routine screening for CMV infection in babies in the UK, delaying treatment that can help improve outcomes.
Through research, we can change this, but we can't do it alone. Can you help with a donation today to support research that could revolutionise the screening of newborn babies for CMV and help protect them from the devastating consequences of CMV?
Together we can help protect babies
With 100% of your gift supporting this research, you really will play a crucial role in transforming the screening of newborn babies for CMV.
Developing a new diagnostic device
Find more about the research, led by Professor Teng, that could transform the screening of newborn babies for CMV.
Mylo's story
Mylo was three months old when tests revealed he had been born with CMV. He underwent treatment with antiviral drugs, that if given soon enough, can help limit the damage caused by the virus, but it soon became clear that it was too late. Now eight years old, Mylo is non-verbal, communicating only by crying and laughing. He also suffers from hearing loss and his mobility is limited to taking just a few steps unaided.
It was difficult to comprehend and still is now how severely Mylo's been affected by CMV when he could have been born asymptomatic or had mild needs.”
